These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 35638310)
41. Inhibition of contact-mediated activation of factor XI protects baboons against Silasi R; Keshari RS; Lupu C; Van Rensburg WJ; Chaaban H; Regmi G; Shamanaev A; Shatzel JJ; Puy C; Lorentz CU; Tucker EI; Gailani D; Gruber A; McCarty OJT; Lupu F Blood Adv; 2019 Feb; 3(4):658-669. PubMed ID: 30808684 [No Abstract] [Full Text] [Related]
42. Factor XI-deficient mice exhibit increased bleeding after injury to the saphenous vein. Ay C; Hisada Y; Cooley BC; Mackman N J Thromb Haemost; 2017 Sep; 15(9):1829-1833. PubMed ID: 28677246 [TBL] [Abstract][Full Text] [Related]
43. Factor XI contributes to thrombus propagation on injured neointima of the rabbit iliac artery. Yamashita A; Nishihira K; Kitazawa T; Yoshihashi K; Soeda T; Esaki K; Imamura T; Hattori K; Asada Y J Thromb Haemost; 2006 Jul; 4(7):1496-501. PubMed ID: 16839345 [TBL] [Abstract][Full Text] [Related]
44. Mice with a deficiency in CLEC-2 are protected against deep vein thrombosis. Payne H; Ponomaryov T; Watson SP; Brill A Blood; 2017 Apr; 129(14):2013-2020. PubMed ID: 28104688 [TBL] [Abstract][Full Text] [Related]
45. Interleukin-8 administration enhances venous thrombosis resolution in a rat model. Henke PK; Wakefield TW; Kadell AM; Linn MJ; Varma MR; Sarkar M; Hawley A; Fowlkes JB; Strieter RM J Surg Res; 2001 Jul; 99(1):84-91. PubMed ID: 11421608 [TBL] [Abstract][Full Text] [Related]
48. Stenosis of the Inferior Vena Cava: A Murine Model of Deep Vein Thrombosis. Payne H; Brill A J Vis Exp; 2017 Dec; (130):. PubMed ID: 29286428 [TBL] [Abstract][Full Text] [Related]
49. Factor XI promotes hemostasis in factor IX-deficient mice. Mohammed BM; Cheng Q; Matafonov A; Monroe DM; Meijers JCM; Gailani D J Thromb Haemost; 2018 Oct; 16(10):2044-2049. PubMed ID: 30007049 [TBL] [Abstract][Full Text] [Related]
50. Recruitment of labelled monocytes by experimental venous thrombi. McGuinness CL; Humphries J; Waltham M; Burnand KG; Collins M; Smith A Thromb Haemost; 2001 Jun; 85(6):1018-24. PubMed ID: 11434678 [TBL] [Abstract][Full Text] [Related]
51. Time-Restricted Salutary Effects of Blood Flow Restoration on Venous Thrombosis and Vein Wall Injury in Mouse and Human Subjects. Li W; Kessinger CW; Orii M; Lee H; Wang L; Weinberg I; Jaff MR; Reed GL; Libby P; Tawakol A; Henke PK; Jaffer FA Circulation; 2021 Mar; 143(12):1224-1238. PubMed ID: 33445952 [TBL] [Abstract][Full Text] [Related]
52. Leveraging Human Genetics to Estimate Clinical Risk Reductions Achievable by Inhibiting Factor XI. Georgi B; Mielke J; Chaffin M; Khera AV; Gelis L; Mundl H; van Giezen JJJ; Ellinor P; Kathiresan S; Ziegelbauer K; Freitag DF Stroke; 2019 Nov; 50(11):3004-3012. PubMed ID: 31558144 [TBL] [Abstract][Full Text] [Related]
53. Factor XII promotes blood coagulation independent of factor XI in the presence of long-chain polyphosphates. Puy C; Tucker EI; Wong ZC; Gailani D; Smith SA; Choi SH; Morrissey JH; Gruber A; McCarty OJ J Thromb Haemost; 2013 Jul; 11(7):1341-52. PubMed ID: 23659638 [TBL] [Abstract][Full Text] [Related]
54. Incomplete resolution of deep vein thrombosis under reduced flow conditions. Cooley BC; Chen CY; Hess R; Schmeling G Thromb Res; 2013 Jan; 131(1):55-8. PubMed ID: 22285299 [TBL] [Abstract][Full Text] [Related]
56. Chymase Inhibition Resolves and Prevents Deep Vein Thrombosis Without Increasing Bleeding Time in the Mouse Model. Lapointe C; Vincent L; Giguère H; Auger-Messier M; Schwertani A; Jin D; Takai S; Pejler G; Sirois MG; Tinel H; Heitmeier S; D'Orléans-Juste P J Am Heart Assoc; 2023 Feb; 12(4):e028056. PubMed ID: 36752268 [TBL] [Abstract][Full Text] [Related]
57. Anti-inflammatory effects of simvastatin during the resolution phase of experimentally formed venous thrombi. Feng Y; Lei B; Zhang F; Niu L; Zhang H; Zhang M J Investig Med; 2017 Aug; 65(6):999-1007. PubMed ID: 28442532 [TBL] [Abstract][Full Text] [Related]
58. MAA868, a novel FXI antibody with a unique binding mode, shows durable effects on markers of anticoagulation in humans. Koch AW; Schiering N; Melkko S; Ewert S; Salter J; Zhang Y; McCormack P; Yu J; Huang X; Chiu YH; Chen Z; Schleeger S; Horny G; DiPetrillo K; Muller L; Hein A; Villard F; Scharenberg M; Ramage P; Hassiepen U; Côté S; DeGagne J; Krantz C; Eder J; Stoll B; Kulmatycki K; Feldman DL; Hoffmann P; Basson CT; Frost RJA; Khder Y Blood; 2019 Mar; 133(13):1507-1516. PubMed ID: 30692123 [TBL] [Abstract][Full Text] [Related]
59. Experimental venous thrombus resolution is driven by IL-6 mediated monocyte actions. Obi AT; Sharma SB; Elfline MA; Luke CE; Dowling AR; Cai Q; Kimball AS; Hollinstat M; Stanger L; Moore BB; Jaffer FA; Henke PK Sci Rep; 2023 Feb; 13(1):3253. PubMed ID: 36828892 [TBL] [Abstract][Full Text] [Related]
60. AKT2 regulates endothelial-mediated coagulation homeostasis and promotes intrathrombotic recanalization and thrombus resolution in a mouse model of venous thrombosis. Xie W; Zhang L; Luo W; Zhai Z; Wang C; Shen YH J Thromb Thrombolysis; 2020 Jul; 50(1):98-111. PubMed ID: 32358666 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]